ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,641,000 | -14.9% | 1,099,801 | -8.1% | 0.03% | -20.0% |
| Q3 2015 | $5,456,000 | -52.1% | 1,196,500 | -24.3% | 0.04% | -47.8% |
| Q2 2015 | $11,402,000 | -4.5% | 1,581,500 | -2.4% | 0.07% | -2.9% |
| Q1 2015 | $11,939,000 | +94.2% | 1,620,000 | +24.6% | 0.07% | +97.1% |
| Q4 2014 | $6,149,000 | +1422.0% | 1,300,000 | +1900.0% | 0.04% | +1066.7% |
| Q3 2013 | $404,000 | -0.5% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $406,000 | – | 65,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |